Search

Your search keyword '"THIEBAUT, Rodolphe"' showing total 452 results

Search Constraints

Start Over You searched for: Author "THIEBAUT, Rodolphe" Remove constraint Author: "THIEBAUT, Rodolphe"
452 results on '"THIEBAUT, Rodolphe"'

Search Results

1. Running in circles: practical limitations for real-life application of data fission and data thinning in post-clustering differential analysis

2. Clonal succession after prolonged antiretroviral therapy rejuvenates CD8+ T cell responses against HIV-1

3. Post-clustering difference testing: valid inference and practical considerations

4. How to improve the quality of comparisons using external control cohorts in single-arm clinical trials?

5. Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)

6. Evaluating the Use of Generalized Dynamic Weighted Ordinary Least Squares for Individualized HIV Treatment Strategies

7. Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report

9. A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease

11. Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: an optimal control approach

12. EpidemiOptim: A Toolbox for the Optimization of Control Policies in Epidemiological Models

15. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

17. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

19. Fr\'echet random forests for metric space valued regression with non euclidean predictors

20. Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

21. Random forests for high-dimensional longitudinal data

22. Supervised Learning for Multi-Block Incomplete Data

23. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

24. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

25. Controlling IL-7 injections in HIV-infected patients

26. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

27. Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine

28. Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial

29. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial

30. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

32. Sequential Dirichlet Process Mixtures of Multivariate Skew t-distributions for Model-based Clustering of Flow Cytometry Data

33. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

34. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

35. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation

36. Modeling CD4+ T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7

37. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

39. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study

42. Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data

43. Heterogeneous Viral Environment in a HIV Spatial Model

45. Mixed models for longitudinal left-censored repeated measures

46. Bivariate linear mixed models using SAS proc MIXED

49. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa

50. Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination

Catalog

Books, media, physical & digital resources